| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |